Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anatomic Stage IV Breast Cancer AJCC v8 × Imatinib Mesylate × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Gastrointestinal Stromal Tumors 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia 5 Neoplasms 3 Neoplasm, Residual 2 Melanoma 2 Hematologic Neoplasms 2 Burkitt Lymphoma 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Cancer 1 Rare Malignant Neoplasm 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Myeloproliferative Disorders 1 Mucositis 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid 1 Leukemia, Biphenotypic, Acute 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Digestive System Neoplasms 1 Desmoid Tumors 1 Dermatofibrosarcoma 1 Congenital Bone Marrow Failure Syndromes 1 Chordoma 1

Interventions

Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Biopsy 2 radium Ra 223 dichloride 1 naxitamab 1 eicosapentaenoic acid ethyl ester 1 eicosapentaenoic acid ethanolamide 1 binimetinib 1 X-Rays 1 Taxes 1 Steroids 1 Photons 1 Paclitaxel 1 Hormones 1 High-Energy Shock Waves 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Cyclin-Dependent Kinase Inhibitor p18 1 Cyclin-Dependent Kinase Inhibitor p16 1 Capecitabine 1 16-fluoroestradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡